Ginkgo Bioworks Up 7% On Higher Q2 Revenue, Raised FY22 Outlook

Shares of cell programming company Ginkgo Bioworks Holdings, Inc. (DNA) are up 7 percent on Tuesday's trading after the company posted a 231 percent rise in second-quarter total revenue to $145 million from $44 million in the comparable prior year period.

The company also raised its expectation for total revenue for 2022 from the $375 - $390 million range to between $425 million and $440 million.

Currently at $3.7450, the stock has traded between $2.0900 and $15.8640 during the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT